Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2596949 | 1.00 | POLB (0.33) | POLB | |
| SCHEMBL2681743 | 0.80 | POLB (0.31) | POLB | |
| SCHEMBL17289563 | 0.75 | CTRC (0.40) | — | |
| SCHEMBL372338 | 0.74 | — | — | |
| SCHEMBL1951120 | 0.73 | — | — | |
| SCHEMBL17607675 | 0.71 | — | — | |
| SCHEMBL28899961 | 0.70 | ALDH1A1 (0.34) | — | |
| SCHEMBL12809869 | 0.69 | ALDH1A1 (0.43) | — | |
| SCHEMBL13325913 | 0.69 | ALDH1A1 (0.43) | — | |
| SCHEMBL12162192 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115074734-B | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-115074734-A | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20100276392-A1 | CMP SYSTEM UTILIZING HALOGEN ADDUCT | CABOT MICROELECTRONICS CORPORATION | 2010-11-04 | — | — | US | disclosed |
| US-7776230-B2 | A chemical-mechanical polishing system comprising an abrasive amd/or a pad, an aqueous carrier and an oxidizer of iodine and a carboxylic acid;high quality polish with minimal surface defects; planarizing substrates | CABOT MICROELECTRONICS CORPORATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-20080057715-A1 | CMP SYSTEM UTILIZING HALOGEN ADDUCT | CABOT MICROELECTRONICS CORPORATION (US) | 2008-03-06 | — | — | US | disclosed |
| US-20050009733-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage | PHARMACIA CORPORATION | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009733-A1 | Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage | KCNJ2, KCNN2, KCNK2 | POLB 3541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.